Loss of MutL Disrupts CHK2-Dependent Cell-Cycle Control through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast Cancer.
- Citation:
- Cancer Discov vol 7 (10) 1168-83
- Year:
- 2017
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 7
- Parents:
- None
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- Pharmas:
- Grants:
- U10CA180821, U10CA180833, U10CA180858, RP120092, P30CA125123, R01 CA095614, T32 GM088129, U10 CA180821, U24 CA196171, U10 CA180882, U10 CA077440, U10 CA180833, U10 CA180858, P30 CA125123
- Corr. Author:
- Authors:
- Svasti Haricharan Nindo Punturi Purba Singh Kimberly R Holloway Meenakshi Anurag Jacob Schmelz Cheryl Schmidt Jonathan T Lei Vera Suman Kelly Hunt John A Olson Jeremy Hoog Shunqiang Li Shixia Huang Dean P Edwards Shyam M Kavuri Matthew N Bainbridge Cynthia X Ma Matthew J Ellis
- Networks:
- CA087, GA005, HEARTLAND, LAPS-MO011, LAPS-TX035, NJ032, OK037, TX041
- Study
- ACOSOG-Z1031
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: